JEC Hosts 5th International Ophthalmology Summit, Launches Groundbreaking Digital Eye Health Platform
JAKARTA, Indonesia, May 22, 2025 /PRNewswire/ -- JEC Eye Hospitals and Clinics, Indonesia's leading eye care provider with more than four decades of clinical excellence, hosts the fifth edition of JEC International Meeting (JECIM) 2025 and launches the nation's first AI-powered digital eye health encyclopedia, Matapedia.
The return of JECIM, after its last edition in 2020, marks a significant moment for global eye care collaboration. Under the theme 'Shaping the Future of Vision,' the three-day scientific forum features pioneering discussions on AI-assisted retinal diagnostics, semi-robotic surgical tools, hospital management for practitioners managing hospitals and eye clinics to meet global standards, a 3D surgery experience—the first of its kind in Indonesia—which allows participants to feel as if they are directly involved in an eye surgery through special glasses, and innovative approaches to combat vision impairment in high-prevalence regions. The forum attracts over 1,200 eye care professionals from 17 countries for groundbreaking discussions on cutting-edge diagnostic tools, surgical innovations, and global strategies to improve vision care. The participants include ophthalmologists—among them young ophthalmologists and members of the ophthalmology community—eye care nurses, optometrists/refractionists-opticians, and other eye health industry practitioners.
DR. Dr. Johan Hutauruk, Sp.M(K), CEO of JEC Corporation said, 'At JEC, our mission is rooted in the belief that a clear vision is fundamental to a better quality of life. Every step we take is driven by a commitment to help people see better—because when people see better, they live better. That belief drives everything we do—especially through platforms like the JEC International Meeting, which we are proud to host as part of our commitment to elevating eye care in Indonesia and beyond. JECIM is more than just a medical symposium—it is a vital convergence of knowledge, innovation, and collaboration. We bring together world-class ophthalmologists, researchers, and professionals to exchange ideas, share the latest breakthroughs, and empower one another.'
JEC International Meeting (JECIM) 2025 is the most comprehensive ophthalmology scientific forum in Indonesia, initiated by JEC and held every two years. JECIM has become the most comprehensive ophthalmology scientific forum in Indonesia— reinforcing JEC's ongoing contribution to advancing eye health not only domestically but also internationally.
Founded in 1984, JEC's legacy as Indonesia's most advanced and comprehensive eye hospital network is well-established, both nationally and internationally. In terms of reach, JEC now operates five state-of-the-art eye hospitals: JEC @ Menteng, JEC @ Kedoya, JEC PRIMASANA @Tj. Priok, JEC CANDI @Semarang, and JEC ORBITA @Makassar. It also runs eleven leading eye clinics in major Indonesian cities, including JEC @ Cibubur, JEC @ Tambora, JEC @ Cinere, JEC @ Bekasi, Candi Eye Center @ Semarang, JEC ANWARI @Purwokerto, JEC JAVA @Surabaya, JEC ORBITA @Makassar, JEC BALI @Denpasar, JEC JAVA @Pasuruan, and the newly opened JEC ORBITA @Kendari. Later this year, JEC will add a few other branches to bring access to trusted, international-standard eye care services closer to not only for local communities, but also for international visitors and even residents of neighboring countries.
Its flagship facility, JEC @ Kedoya, has earned four consecutive accreditations from the Joint Commission International (JCI)—in 2014, 2017, 2020, and 2023—cementing its status as a global-standard institution in patient safety and clinical excellence. This achievement serves as a benchmark for the standardization of JEC's services across all its branches.
A pioneer in vision correction, JEC made history by being the first hospital in Indonesia to introduce LASIK surgery and launch the country's first Laser Vision Correction Center (LVC). For this groundbreaking achievement, JEC was awarded a record by the Indonesian World Records Museum (MURI) for its contributions to LASIK services.
Domestically, JEC has achieved the highest level of accreditation from the Hospital Accreditation Commission (KARS) and received numerous accolades, including the title of Most Brand Reputable Eye Hospital in Greater Jakarta and seven other major cities across Indonesia by SWA Magazine, as well as Best in Building and Managing Corporate Image in the Eye Hospital category from the Corporate Image Award. In addition, JEC was recognized for its excellence in Omnichannel Branding in 2023 and as the winner of the Digital Customer Engagement category at the 2024 Marketeers OMNI Awards.
On the international stage, JEC is a founding member of the ASEAN Association of Eye Hospitals (AAEH) and an active member of the World Association of Eye Hospitals (WAEH), further reinforcing its role as a regional leader in ophthalmic care.
As the most complete eye care provider in Indonesia, JEC offers a full spectrum of advanced treatments, including cataract surgery (Phacoemulsification and FLACS), refractive procedures like SMILE PRO, SMILE, and LASIK, as well as specialized care for corneal diseases, vitreoretinal disorders, glaucoma, and neuro-ophthalmology. JEC also leads in oculoplasty (eye plastic surgery and ocular tumors), ocular infections and immunology, and provides services, namely general eye exams, tele-ophthalmology, dry eye care, contact lens services, and myopia control. For pediatric and specific cases, JEC offers specialized clinics including the Children's Eye & Strabismus Center, Low Vision Care, and the Thyroid Eye Center for thyroid-related vision conditions.
In a groundbreaking move at JECIM 2025, JEC unveiled Matapedia — a comprehensive and accessible digital platform dedicated to eye health. Matapedia serves as a trusted source of accurate, easy-to-understand information about eye conditions, treatments, and preventive care, aiming to empower the public and support medical professionals in enhancing vision and quality of life. All of this information can be accessed free of charge by the general public through the website www.matapedia.id.
Dr. Referano Agustiawan, SpM(K), Director of JEC @ Menteng and Chair of JECIM 2025, said the high-profile gathering has become the ideal stage to introduce this groundbreaking digital solution. 'JECIM has always been about pushing boundaries in eye care. Matapedia, on the other hand, represents a vital bridge between cutting-edge ophthalmology and public accessibility. While JECIM advances professional knowledge sharing, this digital platform extends our expertise directly to communities facing critical eye care shortages.'
Developed in response to Indonesia's severe ophthalmologist shortage - with just 3,000 specialists serving 275 million people - Matapedia combats an equally urgent crisis: medical misinformation. Findings from Indonesia's Communications and Digital Ministry (KOMDIGI), which identified 163 health misinformation cases among 1,923 hoaxes circulating in 2024 are concerning. Given that 27.79% of Indonesians look for health information online, Indonesia's 2024 Digital Literacy Index, however, shows a score of 43,34, indicating that while the public is fairly skilled in using digital devices, they tend to buy the information blindly.
The platform's 'Ask AI' feature provides instant symptom guidance in multiple languages. JEC is also developing a mobile application with full accessibility features for the visually impaired, including screen readers and interactive audio guides. All content undergoes rigorous review by JEC's specialist network, presenting complex medical information through text, audio, and video formats.
DR. Dr. Johan Hutauruk, Sp.M(K), added, 'Matapedia represents the culmination of our 41-year commitment to advancing eye care. This platform bridges our clinical expertise with digital innovation to address critical gaps in eye health education and literacy. From rural health workers to urban families, Matapedia delivers trustworthy knowledge exactly when and where it's needed.'
Initial content covers hundreds of conditions and procedures, with plans to expand to 1,000+ articles by 2026. The forthcoming mobile app will incorporate screen reader technology and interactive audio guides, furthering JEC's commitment to inclusive care.
With a powerful combination of extensive clinical capacity, decades of experience, and the integration of cutting-edge digital technology, JEC continues to strengthen its position as a leader in eye care services in Southeast Asia. Through JECIM and Matapedia, JEC not only advances professional development in the medical field but also creates a meaningful social impact by expanding public access to accurate, high-quality eye health information.
About JEC
With 41 years of experience since its establishment in 1984, JEC's contribution to eye care services has been widely recognized through numerous prestigious awards and achievements. These include four consecutive accreditations from the Joint Commission International (JCI), awarded to JEC @ Kedoya in 2014, 2017, 2020, and 2023; recognition as the first LASIK pioneer in Indonesia, granted to 'JEC LASIK Center' by MURI (Indonesian World Records Museum) in 2007; and Full Paripurna Accreditation from the Indonesian Ministry of Health. JEC has also received accolades such as 'Indonesia Healthcare Most Reputable Brand' in 2014 and 2015 for the eye hospital category in Greater Jakarta and seven major cities in Indonesia from SWA Magazine, and 'Best Corporate Image' from 2015 to 2019.
JEC is a pioneer in establishing the ASEAN Association of Eye Hospitals (AAEH) and remains an active member, alongside its involvement in the World Association of Eye Hospitals (WAEH).
To date, JEC operates five eye hospitals and eleven main eye clinics across major Indonesian cities, including JEC @ Menteng, JEC @ Kedoya, JEC PRIMASANA @Tj. Priok, JEC CANDI @ Semarang, and JEC ORBITA @ Makassar. The clinics include JEC @ Cibubur, JEC @ Tambora, JEC @ Cinere, JEC @ Bekasi, Candi Eye Center @ Semarang, JEC ANWARI @ Purwokerto, JEC JAVA @ Surabaya, JEC ORBITA @ Makassar, JEC BALI @ Denpasar, JEC JAVA @ Pasuruan, and JEC ORBITA @ Kendari.
For more information, please visit www.jec.co.id
Phone: (021) 2922 1000 / Fax: (021) 390 4601 / www.jec.co.id
View original content to download multimedia: https://www.prnewswire.com/apac/news-releases/jec-hosts-5th-international-ophthalmology-summit-launches-groundbreaking-digital-eye-health-platform-302462696.html
SOURCE JEC Eye Hospital and Clinics

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
5 hours ago
- Yahoo
Chatbot platform Character.AI unveils video generation, social feeds
A platform for chatting and role-playing with AI-generated characters, announced in a blog post on Monday that it is rolling out a slate of multimedia features. These features include AvatarFX, video-generation model, plus Scenes and Streams, which allow users to create videos featuring their characters and then share them on a new social feed. " started as 1:1 text chat and today we're evolving to do so much more, inspired by what our users have told [us] they want to see on the platform," the company wrote in the blog post. began rolling out AvatarFX to subscribers last month, but now all users can create up to five videos each day. When creating a video with AvatarFX, users can upload a photo to serve as the basis for the video clip, choose a voice, and write out dialogue for the character. There's an option to upload an audio clip to inform the sound of the voice, though this feature was not working well enough to test upon rollout. Users can turn these videos into Scenes, where their characters can slip into pre-populated storylines that other users create. Scenes are currently available on the mobile app, but Streams, which allows users to create "dynamic moments between any two Characters," is coming this week on both web and mobile. These Scenes and Streams can be shared to a new community feed, which is coming soon in the mobile app. has a track record of abuse on its platform; parents have filed lawsuits against the company, claiming chatbots attempted to convince their children to self-harm, to kill themselves, or to kill their parents. One 14-year-old boy died by suicide after he was encouraged to do so by a bot, with whom he had developed an unhealthy, obsessive relationship. As expands its multimedia offerings, it also expands the potential for these products to be abused. As told TechCrunch when it announced AvatarFX, the platform blocks users from uploading photographs of real people -- whether they're celebrities or not -- and obscures their likeness into something less recognizable. For example, here's uncanny valley version of Mark Zuckerberg: But when it comes to artwork depicting celebrities, does not flag the images as representing real people -- however, these sorts of depictions would be less likely to deceive someone into believing that a deepfake is real. Plus, watermarks each video, though it is possible for bad actors to navigate around that safeguard. Here is an example of an attempted deepfake based on an illustration of Elon Musk: testing the anti-deepfake guardrails on character ai's avatarfx Even if this video had been generated with Elon Musk's actual voice, it would still be relatively clear that this is an animated version of an illustration -- but the possibility for abuse remains evident. "Our goal is to provide an engaging space that fosters creativity while maintaining a safe environment for all," said in its blog post. This article originally appeared on TechCrunch at
Yahoo
5 hours ago
- Yahoo
PAIG AI Rebrands as Trust3 AI to Lead the Way in Trusted AI Adoption
SAN FRANCISCO, June 2, 2025 /PRNewswire/ -- PAIG AI, a leading provider of AI governance and performance solutions, has officially rebranded as Trust3 AI. This strategic rebranding reflects the company's commitment to help enterprises address the growing complexities surrounding AI reliability, governance, and security. Organizations adopting AI today face significant challenges—from ensuring the reliability of AI outputs to managing regulatory compliance and mitigating security risks. Without comprehensive visibility into AI and agent activities across their enterprise, organizations struggle to build the trust necessary for widespread adoption. Trust3 AI aims to simplify that process by equipping businesses with a unified trust layer that ensures confidence at every stage of the AI application lifecycle. The rebranding reinforces our mission to help enterprises seamlessly integrate governance, transparency, and accountability into their AI systems, empowering them to move from experimentation to operationalization without compromise. A Platform Built to Enable Trust Trust3 AI's innovative platform focuses on three core pillars of trust-building across AI systems, Reliability, Governance, and Security: Reliability – Trust3 AI enhances the consistency and accuracy of AI systems by providing domain-enriched semantic layers and AI-driven analytics. It ensures AI systems deliver accurate, efficient, and consistent results to prevent errors, hallucinations, and inconsistent outputs that undermine trust and disrupt business processes. Trust3 AI enables enterprises to deliver dependable outcomes across AI Story: A healthcare client leveraging Trust3 AI achieved a 40% improvement in the accuracy of its clinical AI tools, significantly enhancing patient care outcomes. Governance: With advanced governance tools, Trust3 AI helps enterprises streamline compliance and maintain oversight. Features include continuous audit trails, AI inventories for tracking deployed solutions, and compliance with global frameworks like GDPR and the EU AI Insight: With stricter AI regulations becoming the standard, Trust3 AI simplifies governance, enabling enterprises to focus on scaling innovation while staying compliant. Security: Trust3 AI addresses security concerns by creating robust guardrails to mitigate risks such as malicious use cases and data exposure. Businesses can confidently scale their AI initiatives with proactive risk mapping and adaptive security Stats: 97% of organizations using generative AI report security concerns. Trust3 AI eliminates these risks, fostering safe innovation. Why Trust Matters in AI The name Trust3 AI underscores the company's belief that trust is a continuous process spanning the full App lifecycle with AI . Unlike one-off solutions, the platform integrates reliability, governance, and security into every stage, allowing businesses to deploy AI systems that are as trustworthy as they are innovative. "Trust isn't just a checkbox; it's a competitive advantage. With Trust3 AI, we're not just providing technology, but fostering partnerships to ensure that AI adoption is informed, transparent, and ethical," Neeraj Sabharwal, Co-Founder Trust3 AI, added. Advancing AI with Strategic Partnerships Trust3 AI has also strengthened its capabilities through partnerships with industry-leading platforms like Snowflake and Databricks via their startup accelerator programs. These collaborations enhance the seamless integration of Trust3 AI's solutions, supporting customers across industries as they adopt next-generation AI platforms. Looking Ahead For enterprises ready to overcome the mounting challenges of AI adoption, Trust3 AI represents a transformation—not just a tool. By focusing on the 3 pillars of reliability, governance, and security, Trust3 AI enables the enterprise-ready future of artificial intelligence. About Trust3 AI Based in San Francisco, Trust3 AI (formerly PAIG AI) is a leader in AI governance, security, and lifecycle management solutions. Trust3 AI's unified platform empowers businesses to adopt AI responsibly by building trust into every AI interaction. Trust3 AI is trusted by organizations across industries, from healthcare to finance, and is proud to be part of the Snowflake and Databricks startup accelerator programs. For more information, visit and follow us on Linkedin Media ContactNeeraj Sabharwalmedia@ View original content: SOURCE Trust3 AI Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
7 hours ago
- Yahoo
US FDA launches AI tool to reduce time taken for scientific reviews
(Reuters) -The U.S. Food and Drug Administration said on Monday that it had launched a generative AI tool, Elsa, aimed at improving efficiency across its operations, including scientific reviews. "Today's rollout of Elsa is ahead of schedule and under budget, thanks to the collaboration of our in-house experts across the centers," said FDA Commissioner Marty Makary. The agency said it is already using Elsa to expedite clinical protocol reviews, shorten the time needed for scientific evaluations, and pinpoint high-priority inspection targets. Once the FDA receives an application for a potential drug approval, it has six to 10 months to make a decision. Elsa assists with reading, writing, and summarizing tasks. It can summarize adverse events to support safety profile assessments of drugs and rapidly compare packaging inserts. "Elsa offers a secure platform for FDA employees to access internal documents while ensuring all information remains within the agency. The models do not train on data submitted by regulated industry, safeguarding the sensitive research and data handled by FDA staff," the FDA said. In May, the regulator said it would fully integrate AI by June 30, following an experimental run.